Skip to main content
SpringerLink
Log in

Hirntumoren

  • Chapter
Neurologie

Part of the book series: Springer-Lehrbuch ((SLB))

Zusammenfassung

Sobald eine raumfordernde Läsion in der Schädelhöhle akut ein Volumen von mehr als 50 ml erreicht, wirkt sie komprimierend auf das Hirngewebe und kann zu Funktionsstörungen, z. B. zu einer Lähmung führen. Wenn sie weiter an Volumen zunimmt und lebenswichtige Hirnanteile komprimiert werden, geben diese ihre Funktion auf, der Patient wird bewusstlos und kann an der raumfordernden Läsion sterben. Auch die Geschwindigkeit, mit der sich die raumfordernde Läsion entwickelt, spielt eine Rolle. Beim Erwachsenen kann die starre Schädelkapsel der Volumenvermehrung durch die intrakranielle Geschwulst nicht nachgeben. Die Hüllstrukturen (Dura, Knochen) lassen keine wesentlichen Ausweichmöglichkeiten für einen raumfordernden Prozess zu. Dies gilt nicht für Tumoren im frühen Kindesalter, wenn die Knochennähte und Fontanellen noch nicht geschlossen sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Weiterführende Literatur

  • Bettegowda C, Agrawal N, Jiao Y, et al. (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453–1435

    Article  CAS  Google Scholar 

  • Brandsma D, Stalpers L, Taal W, et al. (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncology 9:453–461

    Article  Google Scholar 

  • Cairncross G, Wang M, Shaw E, et al. (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343

    Article  CAS  Google Scholar 

  • Chinot O, Wick W, Mason W, et al. (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709–722

    Article  CAS  Google Scholar 

  • Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-Oncology 14:Suppl 5:v1–49

    Article  Google Scholar 

  • Fogh SE, Andrews DW, Glass J, et al. (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28:3048–3053

    Article  Google Scholar 

  • Franz DN, Belousova E, Sparagana S, et al. (2013) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomized, placebo-controlled phase III trial. Lancet 381:125–132

    Google Scholar 

  • Gilbert MR, Dignam JJ, Won M, Armstrong TS, et al. (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699–708

    Article  CAS  Google Scholar 

  • Glantz MJ, Cole BF, Forsyth, PA, et al. (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893

    Article  CAS  Google Scholar 

  • Hartmann C, Hentschel B, Wick W, et al. (2010) Patients with IDH1 wild type anaplastic astroctytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718

    Article  Google Scholar 

  • Hegi ME, Diserens AC, Gorlia T, et al. (2005) MGMT gene silencing and response to temozolomide in glioblastoma. N Engl J Med 352:997–1003

    Article  CAS  Google Scholar 

  • Herrlinger U, Felsberg J, Küker W, et al. (2002Gliomatosis cerebri. Molecular pathology and clinical course. Ann Neurol 52:390–399

    Article  CAS  Google Scholar 

  • Jones DT, Hutter B, Jäger N, et al. (2013Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927–932

    Google Scholar 

  • Krüger DA, Care MM, Holland K, et al. (2010) Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363:1801–1811

    Article  CAS  Google Scholar 

  • Landolfi JC, Thaler HT, DeAngelis LM (1998) Adult brainstem gliomas. Neurology 51:1136–1139

    Article  CAS  Google Scholar 

  • Louis DN, Ohgaki H, Wiestler OD, et al. (2007) WHO classification of tumours of the central nervous system. IARC, Lyon

    Google Scholar 

  • Malmström A, Grønberg BH, Marosi C, et al. (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy for patients aged over 60 years with glioblastoma: the Nordic randomized phase 3 trial. Lancet Oncol 13:916–926

    Google Scholar 

  • Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma. Cancer 89:640–646

    Article  CAS  Google Scholar 

  • Pignatti F, van den Bent M, Curran D, et al. (2002Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076–2084

    Article  Google Scholar 

  • Roth P, Wick W, Weller M (2010) Steroids in neurooncology: actions, indications, side-effects. Curr Opin Neurol 23:597–602

    Article  CAS  Google Scholar 

  • Schindler G, Capper D, Meyer J, et al. (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397–405

    Article  CAS  Google Scholar 

  • Schwartzentruber J, Korshunov A, Liu XY, et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482 226–231

    Google Scholar 

  • Soffietti R, Baumert BG, Bello L, et al. (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force. Eur J Neurol 17:1124–1133

    Article  CAS  Google Scholar 

  • Stummer W, Pichlmeier U, Meinel T, et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401

    Article  CAS  Google Scholar 

  • Stummer W, Reulen HJ, Meinel T, et al. (2008Extent of resection and survival in glioblastoma multiforma: identification of and adjustment for bias. Neurosurgery 62:564–576

    Google Scholar 

  • Stupp R, Mason WP, van den Bent MJ, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for patients with newly diagnosed glioblastoma. N Engl J Med 352:987–996

    Google Scholar 

  • Van den Bent M, Brandes AA, Taphoorn M, et al. (2013) Adjuvant procarbacine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC Brain Tumor Group Study 26951. J Clin Oncol 31:344–350

    Google Scholar 

  • Veeravagu A, Jiang B, Ludwig C, et al. (2013) Biopsy versus resection for the management of low-grade glioma. Cochrane Database of Systematic Reviews., Issue 5. Art. No.: CD009319

    Google Scholar 

  • Weller M, Stupp R, Wick W (2012) Epilepsy meets cancer: when, why, and what to do about it? Lancet Oncol 13:e375–e382

    Article  Google Scholar 

  • Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R (2013) Molecular neuro-oncology entering clinical practice: a new horizon. Lancet Oncol 14:e370–e379

    Google Scholar 

  • Wen PY, Macdonald DR, Reardon DA, et al. (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972

    Article  Google Scholar 

  • Westphal M, Hilt DC, Bortey E, et al. (2003A phase 3 trial of local chemotherapy with biodegradable wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology 5:79–88

    Article  CAS  Google Scholar 

  • Westphal M, Ram Z, Riddle V, et al. (2006Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269–375

    Article  CAS  Google Scholar 

  • Wick W, Hartmann C, Engel C, et al. (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. J Clin Oncol 27:5874–5880

    Google Scholar 

  • Wick W, Platten M, Meisner C, et al., for the Neurooncology Working Group (NOA) of the German Cancer Society (2012) Chemotherapy versus radiotherapy for malignant astrocytoma in the elderly. Lancet Oncol 13:707–715

    Google Scholar 

  • Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G (2014) MGMT testing in neurooncology – A paradigm for prospects and challenges of biomarker-based treatment decisions. Nat Rev Neurol 10:372–85

    Article  CAS  Google Scholar 

  • Yan H, Parsons DW, Jin G, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Strahlentherapie, Radiologiesche Univ.-Klinik, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    Dr. Antje Wick

  2. Abteilung Neuroonkologie, Neurologische Univ.-Klinik, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    Prof. Dr. Andreas Unterberg

  3. Neurochirurg. Univ.-Klinik, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    Prof. Dr. Dr. Jürgen Debus

Authors
  1. Dr. Antje Wick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Andreas Unterberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. Dr. Jürgen Debus
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heidelberg, Deutschland

    Werner Hacke

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wick, A., Unterberg, A., Debus, J. (2016). Hirntumoren. In: Hacke, W. (eds) Neurologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46892-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46892-0_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46891-3

  • Online ISBN: 978-3-662-46892-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation